David Gordon MacLeod Lickrish
Chief Executive Officer at Ironshore Pharmaceutical & Development, Inc.
Profile
David Gordon MacLeod Lickrish was the founder of Ironshore Therapeutics, Inc. founded in 2008, where he held the title of President & Chief Executive Officer.
Currently, he is the Chief Executive Officer at Ironshore Pharmaceutical & Development, Inc. Mr. Lickrish's former jobs include being a Research Analyst at Punk Ziegel & Co., an Analyst at HSBC Securities (USA), Inc. from 2005 to 2006, and a Senior Research Analyst at Broadpoint.
Gleacher Securities from 2006 to 2008.
Mr. Lickrish received his undergraduate degree from the University of Guelph.
David Gordon MacLeod Lickrish active positions
Companies | Position | Start |
---|---|---|
Ironshore Pharmaceutical & Development, Inc.
Ironshore Pharmaceutical & Development, Inc. BiotechnologyHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceutical & Development, Inc. develops novel therapeutics using its proprietary controlled-release drug-delivery technology. The company is based in Camana Bay, Cayman Islands. Our lead products are developed using a unique and beneficial delayed-release and extended-release delivery to a specifically targeted area. Ironshore is a fully Caymanian integrated pharmaceutical company with experience developing and commercializing first-in-class therapeutic products. JORNAY PM is a first-in-class product indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. The company is committed to the development and commercialization of first-in-class treatment options to improve the lives of patients and caregivers. The CEO of the company is David Gordon MacLeod Lickrish. | Chief Executive Officer | - |
Former positions of David Gordon MacLeod Lickrish
Companies | Position | End |
---|---|---|
Broadpoint.Gleacher Securities
Broadpoint.Gleacher Securities Investment Banks/BrokersFinance Broadpoint.Gleacher Securities, formerly Broadpoint Capital, Inc. is an independent, institutional investment banking, sales and trading boutique headquartered in New York City. They were also previously known as First Albany Capital, Inc. The firm is a subsidiary of Broadpoint Securities Group, Inc. (Nasdaq: BPSG), formerly known as First Albany Cos., Inc. They have additional offices in Boston, Chicago, Denver, San Francisco, Bonita Springs, Florida, Glen Allen, Virginia, Roseland, New Jersey and St. Louis, Missouri. Broadpoint.Gleacher follows a range of fixed-income securities and provides proprietary views and analysis on credit fundamentals and trading dynamics. They focus on investment grade, high yield and convertible securities in the following sectors: consumer, building materials, financials, gaming / leisure, healthcare, homebuilding, industrials, mining, packaging, paper/forest products, power/energy, technology/media/telecommunications and transportation. | Analyst-Equity | 30/05/2008 |
HSBC Securities (USA), Inc.
HSBC Securities (USA), Inc. Investment Banks/BrokersFinance Founded in 1969, HSBC Securities (U.S.A.) Inc. is an SEC-registered brokerage firm and registered futures commission merchant located in New York City. The firm is a wholly-owned subsidiary of HSBC North America Holdings, Inc. and their ultimate parent is HSBC Holdings Plc. (NYSE: HBC). HSBC Securities (U.S.A.) is a member of FINRA, the NYSE and the SIPC. Their securities and annuity products are provided by registered representatives and insurance agents of HSBC Securities (U.S.A.). In California, HSBC Securities (U.S.A.) conducts insurance business as HSBC Securities Insurance Services. Insurance products are offered through insurance agents of HSBC Insurance Agency (U.S.A.) Inc., a wholly-owned subsidiary of HSBC Bank U.S.A. NA and an indirectly wholly-owned subsidiary of HSBC Holdings plc. The company also engages in investment banking underwriting, dealing and brokering of debt and equity securities and futures contracts and is a primary dealer in U.S. Government and federal agency securities. | Analyst-Equity | 29/09/2006 |
Punk Ziegel & Co.
Punk Ziegel & Co. Investment Banks/BrokersFinance Located in New York City, Punk, Ziegel & Co. is a specialty investment bank providing a full range of research, equity market making and corporate finance services focusing on high growth sectors within the healthcare technology, biotechnology and life sciences industries. Punk, Ziegel's, in-depth securities analysis begins with the identification of high-growth industries and timely investment ideas before they have been fully exploited by the investment community. Within these industry niches, their analysts pinpoint companies offering leadership potential and maximum investment opportunities. Issue-oriented, in-depth analysis is then generated on a continuing basis to insure that their investment and corporate finance advice remains accurate and up-to-date. | Analyst-Equity | 30/01/2005 |
Ironshore Therapeutics, Inc.
Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Chief Executive Officer | - |
Training of David Gordon MacLeod Lickrish
University of Guelph | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Punk Ziegel & Co.
Punk Ziegel & Co. Investment Banks/BrokersFinance Located in New York City, Punk, Ziegel & Co. is a specialty investment bank providing a full range of research, equity market making and corporate finance services focusing on high growth sectors within the healthcare technology, biotechnology and life sciences industries. Punk, Ziegel's, in-depth securities analysis begins with the identification of high-growth industries and timely investment ideas before they have been fully exploited by the investment community. Within these industry niches, their analysts pinpoint companies offering leadership potential and maximum investment opportunities. Issue-oriented, in-depth analysis is then generated on a continuing basis to insure that their investment and corporate finance advice remains accurate and up-to-date. | Finance |
HSBC Securities (USA), Inc.
HSBC Securities (USA), Inc. Investment Banks/BrokersFinance Founded in 1969, HSBC Securities (U.S.A.) Inc. is an SEC-registered brokerage firm and registered futures commission merchant located in New York City. The firm is a wholly-owned subsidiary of HSBC North America Holdings, Inc. and their ultimate parent is HSBC Holdings Plc. (NYSE: HBC). HSBC Securities (U.S.A.) is a member of FINRA, the NYSE and the SIPC. Their securities and annuity products are provided by registered representatives and insurance agents of HSBC Securities (U.S.A.). In California, HSBC Securities (U.S.A.) conducts insurance business as HSBC Securities Insurance Services. Insurance products are offered through insurance agents of HSBC Insurance Agency (U.S.A.) Inc., a wholly-owned subsidiary of HSBC Bank U.S.A. NA and an indirectly wholly-owned subsidiary of HSBC Holdings plc. The company also engages in investment banking underwriting, dealing and brokering of debt and equity securities and futures contracts and is a primary dealer in U.S. Government and federal agency securities. | Finance |
Ironshore Therapeutics, Inc.
Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Health Technology |
Broadpoint.Gleacher Securities
Broadpoint.Gleacher Securities Investment Banks/BrokersFinance Broadpoint.Gleacher Securities, formerly Broadpoint Capital, Inc. is an independent, institutional investment banking, sales and trading boutique headquartered in New York City. They were also previously known as First Albany Capital, Inc. The firm is a subsidiary of Broadpoint Securities Group, Inc. (Nasdaq: BPSG), formerly known as First Albany Cos., Inc. They have additional offices in Boston, Chicago, Denver, San Francisco, Bonita Springs, Florida, Glen Allen, Virginia, Roseland, New Jersey and St. Louis, Missouri. Broadpoint.Gleacher follows a range of fixed-income securities and provides proprietary views and analysis on credit fundamentals and trading dynamics. They focus on investment grade, high yield and convertible securities in the following sectors: consumer, building materials, financials, gaming / leisure, healthcare, homebuilding, industrials, mining, packaging, paper/forest products, power/energy, technology/media/telecommunications and transportation. | Finance |
Ironshore Pharmaceutical & Development, Inc.
Ironshore Pharmaceutical & Development, Inc. BiotechnologyHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceutical & Development, Inc. develops novel therapeutics using its proprietary controlled-release drug-delivery technology. The company is based in Camana Bay, Cayman Islands. Our lead products are developed using a unique and beneficial delayed-release and extended-release delivery to a specifically targeted area. Ironshore is a fully Caymanian integrated pharmaceutical company with experience developing and commercializing first-in-class therapeutic products. JORNAY PM is a first-in-class product indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. The company is committed to the development and commercialization of first-in-class treatment options to improve the lives of patients and caregivers. The CEO of the company is David Gordon MacLeod Lickrish. | Health Technology |
- Stock Market
- Insiders
- David Gordon MacLeod Lickrish